With about 12% of the US population having now received their first dose of the vaccine, the broker believes hospitalisations in the US,
The flipside is this should likely support a further recovery in ultrasound volumes in coming months as elective procedures pick up. Ahead of the company's earnings result, the broker retains Lighten, cutting its target to
Sector: Health Care Equipment & Services.
Target price is
© 2021 Acquisdata Pty Ltd., source